Claritas Pharmaceuticals Inc V.CLAS.H

RE:Patent

[mavericks2020]

but KLY have four mthod to give the R-107

Unlike nitric oxide, which is a gas that must be administered by a trained respiratory therapists using special delivery equipment, R-107 is a liquid that can be easily administered orally in a capsule, or nasally though use of a nasal spray, or by a single intramuscular injection. Due to its ease of administration, R-107 is designed to overcome the challenges inherent in administration of nitric oxide gas, and transform nitric oxide therapy into a potentially best-of-care treatment for COVID-19 infection, and potentially other viral infections as well.